One of the downsides of treatments such as Ozempic or Mounjaro is that even though patients wind up losing weight, they also tend to shed muscle mass. Losing too much muscle mass can be a health risk ...

Nearly two-thirds (64%)  of Americans who have tried weight loss injections report the drugs as being "extremely effective" ...

John M. Burke, MD, examines how new obesity treatments, such as GLP-1 agonists, might influence future cancer rates.

A review of the recent evidence suggests that GLP-1 drugs, such as semaglutide, could protect brain health and cognitive ...

About 165 million Americans rely on employer-sponsored health insurance, and yet workers may still not get the coverage they ...

Popular weight loss drugs are so pricey that many may shell out hundreds or even thousands of dollars on them. Some ...

France is the latest European country to refuse to cover weight loss drugs through its national insurance programme.

There’s a war brewing over blockbuster weight loss medications — and patients are now getting caught in the crossfire.

Three cities in Hawaii, Minnesota, and Texas report the highest usage of injectable weight loss medications. Meanwhile, ...

Diabetes is very common. The Centers for Disease Control and Prevention (CDC) notes that 38.4 million people in the United ...

New data from the CDC and other leading health agencies shows a number of health markers are beginning to improve in the US - ...

While employers typically cover the medications for diabetes, fewer of them do so for weight loss, in part because of the ...